157 filings
Page 5 of 8
8-K
wqun8o
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
8-K
cd82vd289s1cp6jx1df
1 Apr 20
Regulation FD Disclosure
4:39pm
8-K
d4y houue5k6tr4yi
1 Apr 20
Invitae Announces Proposed Public Offering of Common Stock
4:34pm
8-K/A
s0krggbwedtzdxqcw
16 Mar 20
Completion of Acquisition or Disposition of Assets
5:18pm
8-K
4ctn92
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
8-K
i53j4sfks0 zwz6
19 Feb 20
Invitae Reports $216.8 Million in Annual Revenue Driven by More Than 482,000 Samples in 2019
4:08pm
8-K
yrlr3c7h
13 Jan 20
Results of Operations and Financial Condition
5:11pm
8-K
cn602ldue
13 Nov 19
Invitae to Acquire Clear Genetics
4:09pm
8-K
a8zyllak
6 Nov 19
Invitae Reports $56.5 Million in Quarterly Revenue Driven by 129,000 Samples
4:08pm
8-K/A
ucqhyfdc53iwiv460aep
27 Sep 19
Financial Statements and Exhibits
4:16pm
8-K
w2ixdni2ccfcp7mv
18 Sep 19
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:06pm
8-K
2g812ln
11 Sep 19
Invitae Prices Upsized Offering of $300 Million of Convertible Senior Notes
4:07pm
8-K
vjibdrhf867mdpqq2z
4 Sep 19
Invitae Announces Proposed Offering of $200 Million of Convertible Senior Notes
4:54pm
8-K/A
uvik639
28 Aug 19
Statement of Operations
4:05pm
8-K
v8w2ufln moip6
6 Aug 19
Invitae Reports $53.5 Million in Quarterly Revenue Driven by More Than 111,000 Samples in Quarterly Volume
4:17pm
8-K
2jh e3uyx1owdxh2
17 Jul 19
Completion of Acquisition or Disposition of Assets
4:41pm
8-K
x3p jnbmttcaaqxo9p
11 Jul 19
Entry into a Material Definitive Agreement
4:40pm
8-K
df1eyaqh
24 Jun 19
Completion of Acquisition or Disposition of Assets
5:17pm
8-K
b24 mzj9cd
17 Jun 19
Invitae to Acquire Singular Bio to Help Increase Access to Genetic Screening in Early Pregnancy
8:41am
8-K
983n0st
14 Jun 19
Submission of Matters to a Vote of Security Holders
5:25pm